NasdaqCM - Delayed Quote USD

Cadrenal Therapeutics, Inc. (CVKD)

Compare
17.40
-1.60
(-8.42%)
At close: March 3 at 4:00:02 PM EST
17.00
-0.40
(-2.30%)
After hours: March 3 at 6:19:17 PM EST
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
Operating Expense
7,946.02
7,632.84
Operating Income
-7,946.02
-7,632.84
Net Non Operating Interest Income Expense
337.86
231.99
Other Income Expense
--
-956.23
Pretax Income
-7,608.16
-8,357.09
Net Income Common Stockholders
-7,608.16
-8,357.09
Diluted NI Available to Com Stockholders
-7,608.16
-8,357.09
Basic EPS
-6.73
-9.30
Diluted EPS
-6.73
-9.30
Basic Average Shares
1,077.04
899.47
Diluted Average Shares
1,077.04
899.47
Total Operating Income as Reported
-7,946.02
-7,632.84
Total Expenses
7,946.02
7,632.84
Net Income from Continuing & Discontinued Operation
-7,608.16
-8,357.09
Normalized Income
-7,608.16
-7,400.85
Interest Income
337.86
249.09
Interest Expense
--
17.10
Net Interest Income
337.86
231.99
EBIT
-7,608.16
-8,339.99
EBITDA
-7,606.09
-8,338.01
Reconciled Depreciation
2.07
1.98
Net Income from Continuing Operation Net Minority Interest
-7,608.16
-8,357.09
Total Unusual Items Excluding Goodwill
--
-956.23
Total Unusual Items
--
-956.23
Normalized EBITDA
-7,606.09
-7,381.77
12/31/2023 - 1/20/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers